Close

Ratings by Jefferies (Andrew Tsai)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
11/9/2022 Marinus Pharmaceuticals MRNS Maintain Buy
(N/A)
 
 
  Details
7/22/2022 VistaGen Therapeutics VTGN Downgrade Hold
(Buy)
1.07
(0.14)
-86.92% Details
7/6/2022 Vertex VRTX Maintain Buy
(N/A)
 
 
  Details
6/23/2022 Athira Pharma ATHA Downgrade Hold
(Buy)
8.45
(2.87)
-66.04% Details
6/21/2022 Xenon Pharmaceuticals XENE Maintain Buy
(N/A)
 
 
  Details
5/31/2022 Vertex VRTX Maintain Buy
(N/A)
 
 
  Details
5/11/2022 Intra-Cellular Therapies ITCI Maintain Buy
(N/A)
 
 
  Details
3/31/2022 atai Life Sciences N.V ATAI Maintain Buy
(N/A)
 
 
  Details
3/2/2022 Intra-Cellular Therapies ITCI Maintain Buy
(N/A)
 
 
  Details
2/1/2022 Vigil Neuroscience Inc VIGL New Coverage Buy
(N/A)
14.65
(12.71)
-13.24% Details
1/25/2022 Intra-Cellular Therapies ITCI Maintain Buy
(N/A)
 
 
  Details
12/20/2021 Intra-Cellular Therapies ITCI Maintain Buy
(N/A)
 
 
  Details
10/21/2021 Intra-Cellular Therapies ITCI Maintain Buy
(N/A)
 
 
  Details
10/18/2021 Intra-Cellular Therapies ITCI Maintain Buy
(N/A)
 
 
  Details
10/18/2021 Xenon Pharmaceuticals XENE Maintain Buy
(N/A)
 
 
  Details
10/4/2021 Xenon Pharmaceuticals XENE Maintain Buy
(N/A)
 
 
  Details
9/20/2021 Intra-Cellular Therapies ITCI Maintain Buy
(N/A)
 
 
  Details
9/1/2021 atai Life Sciences N.V ATAI New Coverage Buy
(N/A)
15.93
(3.16)
-80.16% Details
8/30/2021 Xenon Pharmaceuticals XENE Maintain Buy
(N/A)
 
 
  Details
8/9/2021 Xenon Pharmaceuticals XENE Maintain Buy
(N/A)
 
 
  Details
6/30/2021 VistaGen Therapeutics VTGN Maintain Buy
(N/A)
 
 
  Details
6/30/2021 Minerva Neurosciences NERV New Coverage Hold
(N/A)
2.41
(3.34)
38.59% Details
6/8/2021 Athira Pharma ATHA Maintain Buy
(N/A)
 
 
  Details
4/19/2021 Sage Therapeutics SAGE Maintain Buy
(N/A)
 
 
  Details
4/19/2021 Intra-Cellular Therapies ITCI Maintain Buy
(N/A)
 
 
  Details
4/16/2021 Athira Pharma ATHA Maintain Buy
(N/A)
 
 
  Details
4/1/2021 Xenon Pharmaceuticals XENE Maintain Buy
(N/A)
 
 
  Details
3/10/2021 Marinus Pharmaceuticals MRNS Maintain Buy
(N/A)
 
 
  Details
2/26/2021 Intra-Cellular Therapies ITCI Maintain Buy
(N/A)
 
 
  Details
2/18/2021 VistaGen Therapeuticsen Therapeutics VTGN New Coverage Buy
(N/A)
1.99
(0.14)
-92.96% Details
12/21/2020 Athira Pharma ATHA Maintain Buy
(N/A)
 
 
  Details
11/6/2020 Sage Therapeutics SAGE Maintain Buy
(N/A)
 
 
  Details
10/13/2020 Athira Pharma ATHA New Coverage Buy
(N/A)
16.81
(2.87)
-82.93% Details
9/15/2020 Marinus Pharmaceuticals MRNS Maintain Buy
(N/A)
 
 
  Details
5/31/2020 Xenon Pharmaceuticals XENE New Coverage Buy
(N/A)
12.70
(36.39)
186.54% Details
1/27/2020 Relmada Therapeutics Inc RLMD New Coverage Buy
(N/A)
40.66
(4.59)
-88.71% Details
9/16/2019 Zynerba Pharmaceuticals ZYNE New Coverage Hold
(N/A)
12.19
(0.56)
-95.41% Details
8/12/2019 Intra-Cellular Therapies ITCI New Coverage Buy
(N/A)
9.23
(52.85)
472.59% Details
7/23/2019 Marinus Pharmaceuticals MRNS Maintain Buy
(N/A)
 
 
  Details
4/25/2019 Sage Therapeutics SAGE New Coverage Buy
(N/A)
166.98
(38.48)
-76.96% Details
3/5/2019 Marinus Pharmaceuticals MRNS New Coverage Buy
(N/A)
3.49
(4.80)
37.54% Details